Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of latanoprostene bunod dosed once
daily (QD) in reducing intraocular pressure (IOP) measured over a 24-hour period in healthy
subjects.